Caffeine for Hypoxic Ischemic Encephalopathy

Clinical trial NCT06855108 · RECRUITING

Trial details

NCT number: NCT06855108
Sponsor: NICHD Global Network for Women's and Children's Health
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hypoxic Ischemic Encephalopathy (HIE)

Start date: 2026-04-08
Primary completion: 2029-12-01
Enrollment: 830

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.